Stephen Cragle, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-257-1126 |
Mrs. Amy Corinne Dearking, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-252-1421 |
Gerald Jurgens, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-257-1166 |
Theodore Truitt, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-257-1126 |
Todd Magnuson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-257-1126 |
Ronald Hanson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1528 Northway Dr, Saint Cloud, MN 56303 Phone: 320-252-0233 Fax: 320-257-1126 |
News Archive
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.
Sybaritic Inc., a medical device maker, has agreed to stop producing and distributing its medical products used in laser surgery, dermatology, and spa treatments until it is in compliance with FDA quality standards.
Among overweight adults, participation in an intensive lifestyle intervention (that included counseling sessions and targets to reduce caloric intake and increase physical activity) was associated with a greater likelihood of partial remission of type 2 diabetes, however the absolute remission rates were modest, according to a study in the December 19 issue of JAMA.
U.S. Senators Tom Harkin (D-IA), Johnny Isakson (R-GA), Jeff Bingaman (D-NM), and Joe Lieberman (I-CT) joined together to take a major step toward stemming the tide of America's eroding preventive medicine and public health workforce.
A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.
› Verified 2 days ago